Main Profile

R&D, Manufacturing, Contract Manufacturing, Exporting, Marketing and Distribution

Description in a few words:

Santa Farma, which was incorporated in 1944 as a privately owned pharmaceutical company, celebrated its 75th anniversary in pharma industry. Ranking among the leading pharmaceutical companies in Turkey, Santa Farma aims to become a local and global contract manufacturing hub for internationally renowned companies along with the support of its brand-new, state-of-the-art manufacturing facility that has the ability to produce solids, semi solids, effervescent tablets and liquids, including a number of specialized forms, such as sachets, pellets, tab-in-caps and bilayer tablets, which is EU-GMP certified. This modern facility has a capacity of 150 million units/shift and the ability. Santa Farma currently offers products developed in its R&D center and manufactured at its premises in nine different therapeutic categories both in local market and in 45 countries in CIS, Asia, Sub-Saharan Africa and Latin America.

Current Leadership:

Erol Kiresepi, Chairman and CEO

Founding Year: 1944

In 2015, Santa Farma moved its manufacturing site to a state-of-the-art manufacturing facility in Dilovasi. The facility is purpose-built and very modern, with a capacity of 150 million packs in one shift, which makes Santa Farma one of the most productive manufacturers Turkey.


Number of machinery in Production and capacities: solid, liquid, sterile

With the help of 124 machines located in its facility, Santa Farma is able to produce 150 million units/shift and the ability to produce solids, semi solids, effervescent tablets and liquids, including a number of specialized forms, such as sachets, pellets, tab-in-caps and bilayer tablets.

Main product categories or therapies of focus

Santa Farma currently markets its products in nine major therapeutic categories including Central Nervous System, Respiratory System, Dermatology, Gastrointestinal System & Metabolism, Hematology, Muscle & Skeleton System, Cardiovascular System, Urogenital System, Gastroenterology & Infection.

Primary packaging production

Santa Farma, as a flexible CMO service provider, offers various collaboration models to its current and also future potential partners, either as bulk production or as finished product supply.

Serialization Service

All packaging lines of Santa Farma Manufacturing Facility are integrated with 2D coding & check weighing systems (OCS brand) and they also end with overwrapping and/or case packing machines (IMA brand).

Total number of delivered boxes/year

Santa Farma currently is able to deliver around 150 million units/shift.


R&D focus

Santa Farma is working to become one of the top three local enterprises in terms of generic pharmaceutical product development with the support of its accredited and modern R&D Center. Santa Farma’s R&D Center, with its 60 scientists and all-new, high-tech equipment, is developing new, value-added generics in novel forms.


Export % in revenues:

Santa Farma’s current export revenue accounts to five percent of its total revenues.

List of export countries:

Azerbaijan, Georgia, Iraq, Vietnam, Kosovo, Yemen, Afghanistan, Kazakhstan, Turkmenistan, Albania

In More Depth

Number of employees

Approximately 1,200 employees in total

GMP certificates

Turkish-GMP, EU-GMP and Jordanian-FDA certificates.

Revenue or Growth Rate in past financial year

Santa Farma’s total revenue grew by 42% compared to past financial year, with the impact of successful performance in the products the company has launched on the market in recent years.

USP/ or a differentiating fact:

High quality one stop shop service provider in Turkey